A clear understanding of the cell type from which SCLC originates, came after the identification of universal biallelic deletion of Rb and TP53 genes in SCLC patients and the development of a genetically engineered mouse model (GEMM) harboring the loss of Rb and TP53 genes in a cell-specific manner. The gene discussed is TP53; the disease is small cell lung carcinoma.